Gemfibrozil + repaglinide in volunteers

Trial Profile

Gemfibrozil + repaglinide in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Repaglinide (Primary) ; Gemfibrozil
  • Indications Hyperlipidaemia; Type 2 diabetes mellitus
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 21 Jul 2011 Results published in Drug Metabolism and Disposition.
    • 14 Jul 2011 New trial record
    • 29 Jun 2011 Results presented at the 10th Congress of the European Association for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top